Member Exclusive Interview

Advancing the discovery of CNS active drugs: an interview with Li Yu and Holger Fischer

At AAPS 2019 PharmSci 360 (3–6 November 2019; TX, USA), we spoke with Li Yu and Holger Fischer (both at Roche; NY, USA and Basel, Switzerland, respectively) to learn more about their work on entrectinib, a novel drug with the ability to cross the blood–brain barrier and treat brain tumors.

Please sign in or register for FREE

No comments yet.